Cargando…
Immunotherapeutic approaches to curtail COVID-19
COVID-19, the disease induced by the recently emerged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has imposed an unpredictable burden on the world. Drug repurposing has been employed to rapidly find a cure; but despite great efforts, no drug or vaccine is presently available for tr...
Autores principales: | Owji, Hajar, Negahdaripour, Manica, Hajighahramani, Nasim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7441891/ https://www.ncbi.nlm.nih.gov/pubmed/32877828 http://dx.doi.org/10.1016/j.intimp.2020.106924 |
Ejemplares similares
-
Harnessing self-assembled peptide nanoparticles in epitope vaccine design
por: Negahdaripour, Manica, et al.
Publicado: (2017) -
The Rise and Fall in Therapeutic Candidates for COVID-19
por: Negahdaripour, Manica
Publicado: (2020) -
A World of Changes: The Inheritance of COVID-19
por: Negahdaripour, Manica
Publicado: (2020) -
COVID-19 Vaccine Global Access Is an Urgency
por: Negahdaripour, Manica
Publicado: (2021) -
The Battle Against COVID-19: Where Do We Stand Now?
por: Negahdaripour, Manica
Publicado: (2020)